A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-386(2)

Clinical trial NCT04694989 · COMPLETED

Trial details

NCT number: NCT04694989
Sponsor: Chong Kun Dang Pharmaceutical
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Hypertension and Dyslipidemia

Start date: 2021-02-20
Primary completion: 2021-04-07
Enrollment: 62

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.